WO2011031948A3 - Prevention of myopia - Google Patents

Prevention of myopia Download PDF

Info

Publication number
WO2011031948A3
WO2011031948A3 PCT/US2010/048397 US2010048397W WO2011031948A3 WO 2011031948 A3 WO2011031948 A3 WO 2011031948A3 US 2010048397 W US2010048397 W US 2010048397W WO 2011031948 A3 WO2011031948 A3 WO 2011031948A3
Authority
WO
WIPO (PCT)
Prior art keywords
myopia
orthokeratology
administration
methods
prevention
Prior art date
Application number
PCT/US2010/048397
Other languages
French (fr)
Other versions
WO2011031948A2 (en
Inventor
Bruce H. Dewoolfson
Dale P. Devore
George E. Glady
Joann Simonsen Glady
Le Thi
Original Assignee
Euclid Systems Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euclid Systems Corporation filed Critical Euclid Systems Corporation
Publication of WO2011031948A2 publication Critical patent/WO2011031948A2/en
Publication of WO2011031948A3 publication Critical patent/WO2011031948A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/142—Cornea, e.g. artificial corneae, keratoprostheses or corneal implants for repair of defective corneal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes
    • G02C7/047—Contact lens fitting; Contact lenses for orthokeratology; Contact lenses for specially shaped corneae
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2202/00—Generic optical aspects applicable to one or more of the subgroups of G02C7/00
    • G02C2202/24—Myopia progression prevention

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Methods of preventing development of myopia by applying an orthokeratology style lens alone or in combination with administration of stabilizing molecules or by administration of stabilizing molecules, including SLRPS and FACITS, without orthokeratology style lens wear to maintain shape and structure, are disclosed. Also described are methods of identifying subject who are predisposed to development of myopia but who have not yet developed myopia.
PCT/US2010/048397 2009-09-11 2010-09-10 Prevention of myopia WO2011031948A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24160709P 2009-09-11 2009-09-11
US61/241,607 2009-09-11

Publications (2)

Publication Number Publication Date
WO2011031948A2 WO2011031948A2 (en) 2011-03-17
WO2011031948A3 true WO2011031948A3 (en) 2014-03-20

Family

ID=43733101

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/048397 WO2011031948A2 (en) 2009-09-11 2010-09-10 Prevention of myopia

Country Status (1)

Country Link
WO (1) WO2011031948A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110112290A (en) 2008-12-22 2011-10-12 더 메디컬 컬리지 오브 위스콘신, 인크. Method and apparatus for limiting growth of eye length
RU2542079C2 (en) * 2013-02-26 2015-02-20 Александр Николаевич Терещук Method for visual acuity training and eyesight recovery
RU2543037C1 (en) * 2013-08-13 2015-02-27 Светлана Юрьевна Клецова Method for prevention of myopia
SG11201900867UA (en) 2016-08-01 2019-02-27 Jay Neitz Ophthalmic lenses for treating myopia
US10884264B2 (en) 2018-01-30 2021-01-05 Sightglass Vision, Inc. Ophthalmic lenses with light scattering for treating myopia
KR20210066789A (en) * 2018-07-12 2021-06-07 사이트글래스 비전 인코포레이티드 Methods and devices for reducing myopia in children
CN113721027A (en) * 2021-07-21 2021-11-30 天津市眼科医院 Application of keratin in preparing medicine for treating/preventing high myopia

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019386A2 (en) * 1999-09-15 2001-03-22 Dewoolfson Bruce H Composition for stabilizing corneal tissue during or after orthokeratology lens wear
US20050105047A1 (en) * 2003-11-19 2005-05-19 Smitth Earl L.Iii Methods and apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions
US20090141235A1 (en) * 2005-02-15 2009-06-04 Queensland University Of Technology Control of Myopia Using Contact Lenses

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019386A2 (en) * 1999-09-15 2001-03-22 Dewoolfson Bruce H Composition for stabilizing corneal tissue during or after orthokeratology lens wear
US20050105047A1 (en) * 2003-11-19 2005-05-19 Smitth Earl L.Iii Methods and apparatuses for altering relative curvature of field and positions of peripheral, off-axis focal positions
US20090141235A1 (en) * 2005-02-15 2009-06-04 Queensland University Of Technology Control of Myopia Using Contact Lenses

Also Published As

Publication number Publication date
WO2011031948A2 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
WO2011031948A3 (en) Prevention of myopia
WO2012097213A3 (en) Methods for diagnosing and treating eye-length related disorders
WO2014120619A3 (en) Compositions and methods of use in treating metabolic disorders
EA201590301A1 (en) COMPOSITIONS AND METHODS OF REDUCING THE CONTENT OF ALCOHOL IN THE BLOOD
PH12015502275A1 (en) Therapuetic uses of empagliflozin
EA201101117A1 (en) DPP-4 INHIBITORS FOR THE TREATMENT OF DIABETES IN CHILDREN
AU338329S (en) Hinge
MX358176B (en) Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders.
WO2014036274A3 (en) Eyewear having removably attached eyewear attachment
WO2009089494A3 (en) Pharmaceutical compositions
WO2012082339A3 (en) Estimating value of user's social influence on other users of computer network system
WO2010062863A3 (en) Compositions containing satiogens and methods of use
NO20082473L (en) Methods, compositions and sets for treating medical conditions
WO2010009478A3 (en) Compositions and methods for treating disorders associated with overweight animals
AU338316S (en) Hinge
WO2010031056A3 (en) Methods and compositions for modulating ire1, src, and abl activity
MX2015013939A (en) Therapeutic uses of empagliflozin.
TWI799741B (en) Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol, and for producing 1,4-butanediol related thereto
AU2010236286A8 (en) Modulation of inflammatory responses by Factor XI
WO2012112419A8 (en) Methods for improving brain development and cognitive function using beta-hydroxy-beta-methylbutyrate
MX2011006725A (en) Combination of aurora kinase inhibitors and anti-cd20 antibodies.
BR112015002295A2 (en) methods and compositions for in vivo induction of pancreatic beta cell formation
MX2015015036A (en) Methods for improving lipid profiles using atrasentan.
WO2009124294A3 (en) Pharmaceutical compositions for binding sphingosine-1-phosphate
EA201491369A1 (en) METHOD OF TREATING DIABETES MELLITUS WITH NON-GLYCOLYNED APOLYPOPROTEIN A-IV

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10816145

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 10816145

Country of ref document: EP

Kind code of ref document: A2